Anabolics & Hormones

Androgen receptor agonists (the steroids and the SARMs), endocrine signals delivered as peptides, incretin mimetics, and the ancillaries taken to manage what the others do. There is no shared receptor here and no shared mechanism of harm. What the subject has in common is a use pattern: healthy people, months at a time, on schedules taken from forums rather than labels, and largely from a grey market in which the contents of a vial are a claim rather than a fact.

That changes the risk model the rest of the tree runs on. The harm here is cumulative and endocrine rather than acute — suppression of the body's own production, lipid and haematocrit shifts, cardiac remodelling over years, liver strain from the oral steroids, infection from injecting. Very little of it announces itself while it is happening, which is the part that makes this subject different from the others.